← Back to Clinical Trials
Recruiting NCT05474196

NCT05474196 Association Between Driving Transpulmonary Pressure and Extravascular Lung Water in Patients with ARDS

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05474196
Status Recruiting
Phase
Sponsor Bicetre Hospital
Condition Acute Respiratory Distress Syndrome
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2022-02-01
Primary Completion 2025-09

Trial Parameters

Condition Acute Respiratory Distress Syndrome
Sponsor Bicetre Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-02-01
Completion 2025-09

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Intubated patients with the acute respiratory distress syndrome (ARDS) are usually treated with protective ventilation limiting plateau pressure below 30 centimeter of water (cmH2O) and, if possible, a driving pressure under 15 cmH2O. However, these airway pressures might not reflect the actual pressure applied to the lung. Transpulmonary pressure is the difference between airway pressure and pleural pressure, the latter is estimated by the esophageal pressure, and so it better reflects the ventilatory induced lung injury (VILI). One of the consequences of the VILI is a increase of pulmonary edema and it could be estimated by the extravascular lung water, obtained by trans-pulmonary thermodilution. So it could exist a link between the driving trans-pulmonary pressure and the extravascular lung water.

Eligibility Criteria

Inclusion Criteria: * Acute respiratory distress syndrome (ARDS) * Monitoring with a transpulmonary thermodilution device * Esophageal pressure monitoring Exclusion Criteria: * Legal protection measures * Pregnancy * Contra-indications of esophageal catheter : esophageal varicose, severe coagulopathy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology